rts logo

Amicus Therapeutics Inc (FOLD) – Don’t Believe the Hype: Check The Facts

Amicus Therapeutics Inc (NASDAQ: FOLD) is -27.20% lower on its value in year-to-date trading and has touched a low of $9.02 and a high of $14.57 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The FOLD stock was last observed hovering at around $10.31 in the last trading session, with the day’s gains setting it 0.02%.

Currently trading at $10.33, the stock is 2.82% and 3.82% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.96 million and changing 0.19% at the moment leaves the stock -9.69% off its SMA200. FOLD registered -14.70% loss for a year compared to 6-month loss of -26.53%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The stock witnessed a 2.79% gain in the last 1 month and extending the period to 3 months gives it a -12.09%, and is 4.87% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.68% over the week and 3.13% over the month.

Amicus Therapeutics Inc (FOLD) has around 517 employees, a market worth around $3.06B and $423.49M in sales. Fwd P/E is 49.22. Profit margin for the company is -34.73%. Distance from 52-week low is 14.52% and -29.10% from its 52-week high. The company has generated returns on investments over the last 12 months (-25.94%).

The EPS is expected to grow by 57.78% this year

The shares outstanding are 293.59M, and float is at 288.09M with Short Float at 8.95%.

Amicus Therapeutics Inc (FOLD) Insider Activity

The most recent transaction is an insider sale by Campbell Bradley L, the company’s President and CEO. SEC filings show that Campbell Bradley L sold 6,100 shares of the company’s common stock on Jul 05 ’24 at a price of $10.00 per share for a total of $61029.0. Following the sale, the insider now owns 0.89 million shares.

Amicus Therapeutics Inc disclosed in a document filed with the SEC on Jul 01 ’24 that Campbell Bradley L (President and CEO) sold a total of 1,400 shares of the company’s common stock. The trade occurred on Jul 01 ’24 and was made at $10.00 per share for $14003.0. Following the transaction, the insider now directly holds 0.89 million shares of the FOLD stock.

Still, SEC filings show that on Jun 03 ’24, Campbell Bradley L (President and CEO) disposed off 7,500 shares at an average price of $10.00 for $75000.0. The insider now directly holds 886,654 shares of Amicus Therapeutics Inc (FOLD).

Related Posts